Postheparin plasma diamine oxidase in health and intestinal disease
- PMID: 2110916
- DOI: 10.1016/0016-5085(90)91081-g
Postheparin plasma diamine oxidase in health and intestinal disease
Abstract
In animals, the distribution of the enzyme diamine oxidase is confined, almost exclusively, to the small bowel mucosa. In humans, plasma diamine oxidase is at or below assay detection limits but can be liberated into the circulation from binding sites in the intestine by i.v. heparin. Therefore, the authors wished to see if diamine oxidase could be released by a low and safe dose of heparin (5000 U) and if the resultant area under the concentration-time curve would provide a noninvasive marker of segmental intestinal disease. In 17 control subjects, the mean area under the curve (following administration of 5000 U i.v. heparin) was 35.9 +/- 5.0 (SEM) mU.L-1.2 h-1; in 6 individuals studied on two separate occasions, postheparin plasma diamine oxidase profiles were reproducible (r = 0.98; p less than 0.001). The longitudinal distribution of diamine oxidase in the gastrointestinal tract, measured in 12 gastric, 16 jejunal, 6 ileal, and 18 colonic biopsies, was similar in humans to that found in animals. In patients with normal peroral biopsies, there was a linear relationship between jejunal mucosal and postheparin plasma diamine oxidase activities (r = 0.84; p less than 0.01). The areas under the curve in controls were then compared with those in patients with segmental intestinal diseases: 21 with ileal disease with or without colonic Crohn's disease (10 unoperated and 11 with ileal resection), 7 with non-Crohn's ileal resection, 8 with ulcerative colitis, 10 with untreated and 7 with treated celiac disease (6 studied before and after a gluten-free diet), and 5 studied during total parenteral nutrition and again after resumption of oral feeding. The results in the 18 ileectomized patients were subdivided into those with major (arbitrarily greater than 75 cm) and minor (less than 75 cm) resections. Areas under the curve were markedly reduced in nonresected Crohn's patients (6.0 +/- 1.79 mU.L-1.2 h-1; p less than 0.001 vs. controls), correlating inversely, in a first-order relationship, with disease activity (r = 0.82; p less than 0.001) and returning toward normal in 4 patients achieving disease remission. Low areas under the curve in total parenteral nutrition patients (4.5 +/- 0.9; p less than 0.001) were also reversible on resumption of oral feeding. However, areas under the curve were not significantly lower in patients with limited ileal resection (less than or equal to 75 cm), with celiac disease (untreated and treated), or ulcerative colitis than in controls.(ABSTRACT TRUNCATED AT 400 WORDS)
Comment in
-
Postheparin plasma diamine oxidase in subjects with celiac disease.Gastroenterology. 1991 Feb;100(2):583-4. doi: 10.1016/0016-5085(91)90250-o. Gastroenterology. 1991. PMID: 1898653 No abstract available.
Similar articles
-
Decreased plasma postheparin diamine oxidase levels in celiac disease.Dig Dis Sci. 1988 Aug;33(8):956-61. doi: 10.1007/BF01535991. Dig Dis Sci. 1988. PMID: 3134178
-
Is the intestine the sole source of heparin-stimulated plasma diamine oxidase? Acute effects of jejunectomy, ileectomy and total enterectomy.Digestion. 1990;46 Suppl 2:439-46. doi: 10.1159/000200419. Digestion. 1990. PMID: 2124565
-
Postheparin plasma diamine oxidase in patients with small bowel Crohn's disease.Gastroenterology. 1988 Dec;95(6):1503-9. doi: 10.1016/s0016-5085(88)80069-6. Gastroenterology. 1988. PMID: 3141238
-
Diamine oxidase: an overview of historical, biochemical and functional aspects.Dig Dis. 1994 Jan-Feb;12(1):2-14. doi: 10.1159/000171432. Dig Dis. 1994. PMID: 8200121 Review.
-
The enzymology of intestinal disease.Clin Biochem. 1987 Apr;20(2):63-72. doi: 10.1016/s0009-9120(87)80101-7. Clin Biochem. 1987. PMID: 3301065 Review.
Cited by
-
Impact of Enterococcus faecium 129 BIO 3B-R on Helicobacter pylori eradication therapy side effects in adult patients: a randomized, double-blind, placebo-controlled study.Sci Rep. 2025 Sep 1;15(1):32085. doi: 10.1038/s41598-025-15864-2. Sci Rep. 2025. PMID: 40890215 Free PMC article. Clinical Trial.
-
Gut Microbiota and Biomarkers of Intestinal Barrier Damage in Cirrhosis.Microorganisms. 2024 Feb 25;12(3):463. doi: 10.3390/microorganisms12030463. Microorganisms. 2024. PMID: 38543514 Free PMC article.
-
Lymphatic diamine oxidase secretion stimulated by fat absorption is linked with histamine release.Am J Physiol Gastrointest Liver Physiol. 2013 Apr 15;304(8):G732-40. doi: 10.1152/ajpgi.00399.2012. Epub 2013 Feb 14. Am J Physiol Gastrointest Liver Physiol. 2013. PMID: 23413254 Free PMC article.
-
Enteral nutrition and the small intestine.Gut. 1994 Dec;35(12):1765-9. doi: 10.1136/gut.35.12.1765. Gut. 1994. PMID: 7829017 Free PMC article. Review. No abstract available.
-
Noninvasive Biomarkers of Gut Barrier Function in Patients Suffering from Diarrhea Predominant-IBS: An Update.Dis Markers. 2020 Oct 13;2020:2886268. doi: 10.1155/2020/2886268. eCollection 2020. Dis Markers. 2020. PMID: 33110455 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials